Skip to main content
OpenTrials
Completed

NCT Number: NCT02514317

Percutaneous Treatment of Carpal Tunnel Syndrome With Scan

The objective of the study is to evaluate in patients suffering from carpal tunnel syndrome resistant to medical treatment, clinical course after percutaneous treatment under ultrasound guidance. 40 patients will be included in the study. The following parameters will be evaluated: patient satisfaction, pain, functional disability, quality of life and time to return to work. The medico-economic aspect will be analyzed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Carpal Tunnel Syndrome Cumulative Trauma Disorders Median Neuropathy Mononeuropathies Nerve Compression Syndromes Nervous System Diseases Neuromuscular Diseases Peripheral Nervous System Diseases Sprains and Strains Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

University Hospital

Caen, 14000, France

About this study

Ultrasound analysis of Carpal tunnel is used for many years, especially for diagnostic purposes. Investigators have shown, first by a study of 104 cadavers that it was possible to reduce the opening by making the gesture under ultrasound guidance and to perform the procedure under local anesthesia. Then investigators performed an open study of 25 patients confirming the absence of iatrogenic lesions with this new technique.

The percutaneous treatment of carpal tunnel syndrome under ultrasound guidance is a gesture of interventional radiology. One can envisage making this type of treatment in interventional radiology room which overcomes the operating room and thus reduce costs.

The objective of the study is to continue the study of percutaneous treatment of carpal tunnel syndrome under ultrasound guidance by an open study conducted in interventional radiology room.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient older than 18 years who signed the informed consent.
  • Patient with an Carpal Tunnel Syndrome

Exclusion criteria

  • patient has already undergone surgery of Carpal Tunnel Syndrome
  • Patient with contra-indications to anesthesia (heart failure, kidney, liver).
  • Pregnant women
  • alcoholics in weaning period
  • Patient whose consent is altered or unable to get a safety procedure
  • Patient with contra-indication to lidocaine
  • Patient with contra-indication for the realization of ultrasound endoscopy (carpal tunnel syndrome secondary or anastomosis between the median and ulnar nerves: anastomosis Berritini)

Treatment and study plan

Percutaneous treatment

Procedure

Ultrasound

Device

Primary outcomes

  1. Pain (visual analogic scale)

    Time frame: change between baseline and day 90 after surgery

    visual analogic scale

  2. paresthesia

    Time frame: change between baseline and day 90 after surgery

  3. muscle strength (dynamometer JAMARD)

    Time frame: change between baseline and day 90 after surgery

    dynamometer JAMARD

Sponsors and collaborators

Lead sponsor

University Hospital, Caen

Other

Registry information

Official study title

Ultrasound-assisted Percutaneous Release of Carpal Tunnel Syndrome

Acronym: ECHOCARPE

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Aug 3, 2015
Registry last updated
Apr 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.